Steward Partners Investment Advisory’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

Steward Partners Investment Advisory’s Portfolio SCMP Stock Details SCMP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-300	Closed	-$5K	–	2420
2017 Q4	$5K	Hold	300	–	–	﹤0.01%	1547
2017 Q3	$3K	Hold	300	–	–	﹤0.01%	1453
2017 Q2	$3K	Hold	300	–	–	﹤0.01%	1382
2017 Q1	$3K	Hold	300	–	–	﹤0.01%	1280
2016 Q4	$4K	Buy	+300	New	+$4.18K	﹤0.01%	700

Other funds holding SCMP

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

AIM

Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Steward Partners Investment Advisory's SCMP Position: Q1 2018 in Review

Steward Partners Investment Advisory sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q1 2018, closing a stake of 300 shares — an estimated $5K sold.

Steward Partners Investment Advisory first reported a position in SCMP in Q4 2016 and held it in 5 quarters. The position peaked at $5K in Q4 2017. 3 funds tracked by Wall St. Rank hold SCMP as of Q1 2018.

Steward Partners Investment Advisory reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
Steward Partners Investment Advisory sold 300 Sucampo Pharmaceuticals, Inc. shares in Q1 2018, an estimated $5K.
Steward Partners Investment Advisory first reported a position in Sucampo Pharmaceuticals, Inc. in Q4 2016 and held it in 5 quarters.
Steward Partners Investment Advisory's Sucampo Pharmaceuticals, Inc. position peaked at $5K in Q4 2017.
3 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q1 2018.

Based on Steward Partners Investment Advisory's 13F filing for Q1 2018, filed 20 Apr 2018.